AGILITY INNOVATION EXECUTION AND EXPANSION - Building a globally dominant cannabis company - Squarespace
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
AGILITY INNOVATION EXECUTION AND EXPANSION Building a globally dominant cannabis company JANUARY 2018
Forward Looking Statements This Presentation (the “Document”) by Aurora Cannabis Inc. (“Aurora” or the “Company”) has been compiled by management of the Company solely for information purposes. The Document has been prepared and dated as of March 31, 2017, and the information contained herein is current as of such date only. The Document under no circumstances is to be construed to be an offering of securities. Neither this Document, nor its delivery to the recipient shall constitute an offer to sell, or the solicitation of an offer to buy the assets described herein. It is provided solely for use by prospective investors in considering their interest. The information contained herein has been prepared to assist interested parties in making their own evaluation of the Company and its business and does not purport to contain all the information that prospective investors may require. Prospective investors should conduct their own investigation and analysis of the Company and its business and the information contained in this Document as well as any additional information provided by the Company. This Document includes forward-looking statements within the meaning of certain securities laws, including the “safe harbour” provisions of the Securities Act (Ontario, Alberta and British Colombia) and other provincial securities law in Canada. These forward- looking statements include, among others, statements with respect to our objectives, goals and strategies to achieve those objectives and goals, as well as statements with respect to our beliefs, plans, objectives, expectations, anticipations, estimates and intentions. The words “may”, “will”, “could”, “should”, “would”, “suspect”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”, “expect”, “intend”, “forecast”, “objective” and “continue” (or the negative thereof), and words and expressions of similar import, are intended to identify forward- looking statements. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, which give rise to the possibility that predictions, forecasts, projections and other forward-looking statements will not be achieved. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. The Company strongly cautions readers not to place undue reliance on these statements, as a number of important factors, many of which are beyond our control, could cause the Company’s actual results to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates and intentions expressed in such forward-looking statements. These factors include, but are not limited to: general economic conditions; pending and proposed legislative or regulatory developments in Canada including the impact of changes in laws, regulations and the enforcement thereof; reliance on funding models in Canada; operational and infrastructure risks including possible equipment failure and performance of information technology systems; intensifying competition resulting from established competitors and new entrants in the businesses in which the Company operates; insurance coverage of sufficient scope to satisfy any liability claims; fluctuations in total patients and customers; technological change and obsolescence; loss of services of key senior management personnel; privacy laws; structural subordination of common shares; leverage and restrictive covenants; fluctuations in cash timing and amount of capital expenditures; tax-related risks; unpredictability and volatility of the price of the Company’s securities; dilution; and future sales of the Company’s securities. The foregoing list of important factors that may affect future results is not exhaustive. When reviewing the Company’s forward-looking statements, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Except as required by Canadian securities law, the Company does not undertake to update any forward-looking statements, whether written or oral, that may be made from time to time by the Company or on the Company’s behalf. Such statements speak only as of the date made. The forward-looking statements contained in this Document should not be relied upon as representing the view of the Company or its management as of any date subsequent to the date of this Document. Neither the Company nor its management is under any obligation, and neither undertakes, to update any of this information at any particular time. Neither the Company nor its management assumes any obligation to update or revise forward-looking statements should circumstances or estimates or opinions changes. None of the Company or its affiliated or related partnerships and corporations or their respective directors, officers, partners, employees, agents or representatives makes any representation or warranty as to the accuracy or completeness of the Document or any statements, estimates or projections, and none will assume any liability for any representations (express or implied) contained in, or for any omissions from, the Document, or for any other written or oral communications transmitted to prospective investors in the course of their evaluation of the Company and its business. An investor will only be entitled to rely on those representations and warranties contained in the definitive agreement or agreements which constitute the financing. This presentation can not be copied, reproduced or distributed in whole or in part to others, at any time, without the prior express written consent of the Company. To the extent that they are included in this document, certain financial metrics can be reported as non-IFRS measures, such as EBITDA (earnings before interest, taxes, depreciation and amortization). For the purposes of this Document, EBITDA is calculated as revenue less cost of sales and operating expenses. The Company believes that these non-IFRS measures are appropriate measures of the operating performance of the Company. The Company’s calculation of these measures may differ from the methodology used by other issuers and, accordingly, may not be comparable to such other issuers. The Company believes that these measures are appropriate measures of the Company’s operating performance because they facilitate an understanding of operating performance without giving effect to certain non-cash and overhead expenses. None of these measures are equivalent to net income or cash flow from operating activities determined in accordance with IFRS. Aurora Cannabis Inc. Management Presentation 2
EXCEPTIONALLY PROJECTED MARKET POTENTIAL
WELL POSITIONED TO CANADA EU
$12 B1 $37 B1
CAPITALIZE ON THE
GLOBAL CANNABIS ROW
OPPORTUNITY $110 B1
1VIII Capital, Cannabis Sector, July 2017
AGILITY INNOVATION EXECUTION EXPANSION
Talented, experienced management team driving the sector's
fastest growth in customers, revenues and shareholder value
4
Agility
Fastest Growing LP’s – Sales License to 650kg/quarter
• Fastest ramp up, execution
and sales growth achieved
relative to other LP’s
• Focused strategy aimed at
capitalizing on vertical and
horizontal integration
opportunities internationally
and domestically Source: SEDAR filings
Aurora Active Registered Patients
25,000
20,000
20,000
16,000
15,000 13,100
12,000
10,000 7,700
5,000 3,000
0 310
0
Jan '16 Feb '16 May '16 Aug '16 Dec '16 Mar '17 Jun '17 Sep '17
Aurora Cannabis Inc. Management Presentation 5
Innovation Across all Operational Areas
Establishing a world-leading brand, scale and efficiencies
CUSTOMER CULTIVATION Strategic
EXPERIENCE Partnerships
CUSTOMER SERVICE AURORA SKY RADIENT TECHNOLOGIES
• The Aurora Standard: • World’s largest and most technologically (Strategic Partnership, 17.23% interest)
leading edge customer care advanced cannabis cultivation facility • Joint development of superior,
• Only LP with mobile app for • Optimized for highest yield and lowest proprietary oil extraction process
purchasing medical cost per gram produced • Faster, more efficient and higher
cannabis AURORA VIE throughput
• Same-day delivery in • Specialty strains • Better terpene preservation
Calgary, Edmonton and
surrounding areas • Yield-optimized indoor facility NamasteMD – exclusive white label use
AURORA MOUNTAIN for CanvasRx
• e-Commerce
• First fully purpose-built indoor cannabis Micron Waste Technologies (9%
• Product differentiation interest) – low-cost environmentally
facility
friendly treatment of organic waste
Aurora Cannabis Inc. Management Presentation 6
Scale, Reach & Differentiation
EXECUTION • Year on Year revenue growth 169% (Q1 2018/2017)
• > $700 M pro-forma cash and marketable securities balance to fuel
domestic and international expansion
STRONG REVENUE GROWTH • Construction of industry-leading facilities on schedule
• Pedanios acquisition - largest German distributor
CAPITAL MARKETS PROGRESSION • BC Northern Lights and Urban Cultivator acquisitions – proprietary
systems for indoor cultivation of cannabis and organic microgreens
• H2 Biopharma acquisition – expansion in Quebec
CAPITALIZATION
• Cann Group investment - first Australian licensed cannabis company
• Radient investment – superior extraction technology
DOMESTIC EXPANSION • Hempco investment – ancillary product offerings and potential
access to substantial supply of low-cost CBD
• Namaste strategic supply, distribution and exclusive agreement to
GLOBAL EXPANSION white label NamasteMD platform
• Acquisition Larssen, formation ALPS, industry leading design and
consulting operation
HORIZONTAL INTEGRATION
• Denmark – 51% in JV building Europe’s largest cannabis facility
• Investment in TGOD – access to >20,000 kgpa premium organic
cannabis and potential to benefit from financial performance TGOD
• CannaRoyalty – access to drug delivery technologies
7
Domestic Expansion
Positioned for rapid growth of medical and adult consumer markets
Aurora Mountain one of only a few EU GMP Certified cannabis
production facilities
MOUNTAIN SKY VIE LACHUTE
Footprint 55,000 800,000 40,000 48,000
(square
footage)
Status Operational Completion by mid- Completed and Completion Q1
$ 9.0+ Billion
since 2015 2018 Licensed Nov 2017 calendar 2018 adult consumer market opportunity in
First bays ready for First harvest
planting Dec 2017 Jan/Feb 2017 Canada1
3.4 million Canadian marijuana users***
Capacity 4,800 kg/yr 100,000+ kg/yr 4,000+ kg/yr 4,500+ kg/yr
Nationwide legalization
Key features First purpose Highly automated, Technologically Nearly Potential for new product forms & devices
built cannabis technologically advanced, completed, state-
facility advanced cannabis specialty strains for of-the art facility
$ 3.0 Billion
facility for optimized premium products to be completed
EU GMP yield and low cost and medical to EU GMP
certified production built to EU research standards
GMP standards. medical cannabis market opportunity in
Completed to EU
Located at Edmonton Canada1
GMP standards
international airport
for superior domestic
and global distribution 8
1 VIII Capital, Cannabis Sector, July 2017
logistics
Strategic Partnership with TGOD – Further Capacity and
Differentiation Through Premium Organic Products
RAINWATER
RESERVOIR
• Aurora is completing a strategic ENERGY
ROOM WASTE
MANAGEMENT Ancaster facility
investment in The Green Organic HST
BUILDING 2
Dutchman (TGOD) SUPPORT
AREA
• Aurora will own 17.62% of TGOD, with
option to increase interest to >50% BUILDING 1
Valleyfield facility
• Agreement includes supply agreement,
providing access to 20% of TGOD output
from Ancaster and Valleyfield facilities
MOTHER PLANT
PROPAGATION
VEGETATIVE
FLOWERING
Larssen Ltd
GREENHOUSE ENGINEERING
• TGOD is building 820,000 sqft ALPS-
designed facility in Valleyfield, Quebec
• TGOD is completing expansion of Adding > 20,000 kg p.a.
existing Ancaster (On) facility to 150,000 in premium organic
sqft cannabis product to
• Will have >100,000 kg per annum Aurora portfolio
production capacity
Aurora Cannabis Inc. Management Presentation 9
INTERNATIONAL EXPANSION AND
PRODUCT DIFFERENTIATION
10Pedanios – Aurora’s Gateway
to the EU Cannabis Market
• Largest medical cannabis distributor in EU
• EU GMP certified for import, release and
distribution of cannabis
• Currently servicing >2,000 pharmacies in
Germany (exclusive suppliers of patients)
• Access to single largest federally legalized
medical cannabis market with population
> 82 million
• Broad insurance coverage for prescribed
medical cannabis
• Limited number of EU GMP certified
international producers currently serving
the German market
• Cornerstone acquisition for European 82 million >400 million
expansion strategy population Germany population EU
• In phase 2 of tender process for German
cultivation license
11Aurora Nordic – Europe’s Largest Facility
at 1,000,000 Square Feet
Nordic focus wth
• Aurora Nordic: 51/49 JV with Alfred option to export
Pedersen, one of Europe’s largest
greenhouse growers of vegetables to wider EU with
(>100,000 kg per day)
> 400 M people
• Licensed to produce as of Jan 1, 2018
• To construct ALPS-designed high-
technology facility
• At 1,000,000 sqft, this will be largest
cannabis facility in Europe JV Partner Recognized
• Focused on Nordic countries and as one of Denmark’s
export to rest of EU through Pedanios leading entrepreneurs
• Built to EU GMP standards for export
• Prior to facility being completed, JV has
82 million
access to temporary greenhouse space population Germany
for cultivation of cannabis
12CANN GROUP: Australian Market Opportunity
• 22.9% stake in Cann Group Ltd for AUSTRALIA
$6.6 million (initial investment at AUS
>24 million
$0.30/share)
• Significant appreciation of initial
investment since listing population
• Technical Services Agreement in place
• Possession of one of the first two Licenses
issued in Australia
• Cultivation, Sales, and R&D licenses
• 3 facilities contemplated
• First harvest completed
330% return on investment
Current
• Australia is a new market with significant Shares bought
Date Price Costs Price (Jan Current value
(million)
development potential 9, 2017)
25-Apr-17 21.6 0.31 6.696 3.6 77.76
08-Dec-17 7.2 2.42 17.424 3.6 25.92
TOTAL/Averag
28.8 0.8375 24.12 3.6 103.68
e
Aurora Cannabis Inc. Management Presentation 13Vertical Integration – Aurora Larssen Projects Ltd. (ALPS) • Formed following acquisition of Larssen Ltd. • Global leading greenhouse engineering and design consultancy • Responsible for Aurora Sky • Currently engaged by 15 cannabis companies globally, including 5 LPs • 30 year track-record delivering technologically advanced, yield-optimized greenhouse facilities for cannabis and other horticultural sectors • Tracking for $6M in Fiscal 2018 revenues Creating a Global Turnkey Cannabis Cultivation Powerhouse Aurora Cannabis Inc. Management Presentation 14
Horizontal Integration - Strategic Relationships
Hempco Food and Fiber Investment Namaste
• Potential future ownership > 50% • Leading e-Commerce supplier of cannabis
vaporizers
• Well-established, pioneer distributors of
hemp products • Serves growing need for smokeless solutions
and growing demand for ancillary products
• Provides access to hemp – a large, low-cost
and sustainable source of CBD to support • Promotes wider brand recognition in
growing demand for cannabis products anticipation of legalization of the adult
recreational market
• Ancillary product offerings for horizontal
integration - nutritional supplements and • Now also acting as third-party distributor for
health-lifestyle products BCNL products
• Exclusive white label use of NamasteMd by
CanvasRx
Aurora Cannabis Inc. Management Presentation 15FINANCIAL SECTION
16Operating Metrics and Assumptions
AURORA MOUNTAIN: LACHUTE FACILITY
• Consistent production at capacity during the last • Further exposure to underserved Quebec market
two quarters with additional 4,500 kg/yr capacity and significant
expansion potential
• Continued production expected at 4,800 kg/yr
• Facility to be completed to EU GMP standards
• First harvest expected Q2 calendar 2018
AURORA SKY:
• First bays ready for planting
• First harvest and inventory build expected by April 2018 SALES PRICES:
• Capacity of 100,000 + kg/yr expected by June 2019 • Sales prices in Canadian and Germany medical
markets expected to remain steady for several years
• Selling prices in Canadian adult consumer market
VIE: may vary by province depending on distribution
• Planting commenced November 2017 model
• First harvest and sales expected early 2018
• Capacity of approx 4,000 kg/yr expected by early 2019 CASH PRODUCTION COST PER GRAM:
• As Aurora Sky ramps up, ACB’s average cash
production cost per gram expected to fall to below
$1.00/gUnit Economics
Current Aurora Metrics Outlook
Sales Price per Gram/Gram equivalent Sales price per gram/gram equivalent for dried
Canada – CAD $9/g cannabis products expected to be stable with
global demand exceeding supply.
Europe - > € 8/g (~CAD11.80/g)
Higher margin expected on concentrates and
Cash cost to produce (Q1 2018) other derivative cannabis products.
$1.73/g
Cost per gram expected to decrease with
automation, scale and yield expertise realized.
Cash cost to sell (Q1 2018)
$1.92/g Long term SG&A costs not expected to escalate at
the same rapid pace of projected revenue and
market growth given regulatory marketing
restrictions and economies of scale.
18Strong Revenue Growth
Sequential
Growth (%) 457.1% 151.7% 26.5% 33.2% 14.7% 39.0%
Revenue ($M)
$9.0
$8.2
169%
$8.0
YoY growth
for Q1 2018
$7.0
$5.9
$6.0
$5.2
$5.0
$3.9
$4.0
$3.1
$3.0
$2.0
$1.2
$1.0
$0.2
$0.0
Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017 Q1 2018
Aurora Cannabis Inc. Management Presentation 19Continuously Improving Metrics
Q1 2018 Q4 2017 Q3 2017 Q2 2017
# # # #
Active registered patients (1) 19,280 16,400 13,110 12,200
Grams sold 889,965 755,059 653,008 538,045
Grams produced (2) 1,009,585 1,164,683 846,849 670,322
(In CDN $000’s unless otherwise noted) $ $ $ $
Average net selling price per gram 8.22 7.45 6.64 5.96
Cash cost of sales per gram 1.92 2.09 2.31 2.56
Cash cost to produce per gram 1.73 1.91 1.91 2.13
Cash and cash equivalents 127,915 159,796 111,116 55,846
Working capital 169,674 170,142 126,530 60,060
Aurora Cannabis Inc. Management Presentation 20Value Creation Through Strategic Investments
Shares Average Current
Company invested in RoI
bought price Value
# $ $ %
Radient Technologies 28.8 0.84 103.7 330
Cann Group 23.2 0.57 50.8 285
Hempco Food and Fiber 10.6 0.31 19.8 519
TOTAL $174.3 330%
Exceptional investment track record
Currently completing investment agreements with TGOD and Micron Waste Technologies
Aurora Cannabis Inc. Management Presentation 21OUR ASSETS
22Aurora Mountain – First Large-Scale Purpose-Built EU GMP Certified
Cannabis Facility
55,200 sq. ft. purpose-built, state of the art facility 7.7M sq. ft. of land available for facility expansion
4,800kg Current annual capacity Only Fully licensed producer in Alberta
13 Licensed grow rooms: 10 flower, 1 clone,
1 mother, 1 micro-propagation One Of the largest production facilities in
Canada
State of the art, scalable, EU GMP certified production facilityAurora Sky Will Be the World’s Most Technologically Advanced And
Largest Capacity Cannabis Facility
~800,000 square feet
100,000+ kg p.a.
• World leading design & supply partners
• First bays ready for planting
• Highest-yielding greenhouse per kWh of energy
consumed
• World’s first facility located at international
airport
• Estimated capital cost $120 million
• At full capacity, Aurora Sky is estimated to
produce over 100,000 kg per year
24Facility Features Aimed at Yield and Cost Optimization • Forced air, over pressurized with tailored filters on inlet/outlet • Sealed greenhouse enables energy conservation, minimizes disease pressure • Design supports unsurpassed light availability and penetration • Best-in-class uniform climate control throughout grow zones • Specialized irrigation system supports health, minimizes waste • Focus on optimized yield, quality, flavor/aroma • Fully integrated computer monitoring & control across entire life cycle • Mobile bench system and automated plant movement • Integrated visual monitoring systems to identify pests, disease and other problems • Harvest to dry provides small-batch quality with mass scale throughput • Custom process-flow supports production under strict GMP/GPP standards Aurora Cannabis Inc. Management Presentation 25
Optimal Logistics at Edmonton International Airport (EIA)
AURORA SKY
Advantages
• Unparalleled access to transportation for
domestic and international distribution of
products servicing Aurora’s expanding
footprint
• Access to industrial infrastructure, power,
water and gas
• Federal security monitoring
• Co-location with bonded warehousing
and courier services
• Edmonton has the lowest corporate tax
rate in North America
• Property taxes at the Edmonton
International airport are approximately
half of those charged in Edmonton
Aurora Cannabis Inc. Management Presentation 26Aurora Vie and Lachute Quebec facilities
• Acquired Peloton Pharmaceuticals for $7 million
• 40,000 square foot facility completed and first
planting commenced November 2017
• Completed build-out and received license in
November 2017, reflecting unparalleled execution
in sector
• Provides direct access to Quebec market
• Provides operations base to target, and shortens
supply lines to serve, Atlantic Provinces
• Delivers additional supply
• H2 Biopharma acquired December 2017
• Certain technologies proposed for Aurora Sky to • 48,000 sqft nearly completed facility
be tested at Pointe-Claire facility • 4,500 kg/yr capacity
• 46 acres expansion land under option to
acquire for $136,000
Aurora Cannabis Inc. Management Presentation 27OUR PRODUCTS
28Aurora Dried Flower Products Recognized for High Quality
WIDE RANGE OF HIGH-DEMAND PRODUCTS
24
Distinct Strains in Production ►
Dried Bud and Oils
10+ Flagship Strains Differentiated by:
▪ THC%: < 1% – 32% (Highest reported in Canada)
▪ CBD%: < 0.5% – 20+% (Highest reported in Canada)
▪ Types: Indica, Sativa, Hybrid, Blend
Sundance Ambition Sentinel
24
(Borealis Blend) (Blue Dream) (Cannatonic)
Product Strains Launched to Date
• Highest CBD Strain in Canada
• Highest THC Strain in Canada
0 Pesticides and Gamma-irradiation ►
Natural, Differentiated
• Mid-range THC Strains
• Balanced THC/CBD Strains
$9 per Gram; $6/gram compassionate pricing
The Aurora brand resonates with the Canadian Medical Cannabis Community and Adult Use CultureCannabis Oils – Sales & Continued Innovation
• Sales license received January 2017 • Game-changing collaboration with Radient
• Sales of four product lines • Proprietary technology with the potential for:
commenced in April 2017
• Better Terpene preservation
• Sales price - $95 per 30ml bottle • Significantly reduced extraction times (minutes vs
($65 compassionate pricing) hours for current benchmark)
• Lower production costs
• Higher active ingredient purity
• Increased recovery of actives from scarce biomass
• Utilization of significantly less energy and material
inputs than current benchmark processes
• Collaboration grants exclusivity related to the
use of the technology in Canada
Aurora Cannabis Inc. Management Presentation 30Product Differentiation – Enabling The Homegrow Market Industry-leading grow boxes for the homegrow market Urban cultivators for microgreens for both the residential and commercial kitchen markets Endorsed by celebrities and corporations Aurora Cannabis Inc. Management Presentation 31
Hempco – New Products, New Markets, Low-Cost CBD Supply
One of the world’s largest industrial producers
of hemp products
• Primary product lines:
• Bulk and packaged food products (e.g. hemp protein
powder, hemp seeds or hearts, hemp oil
• Hemp fibre
• Nutraceuticals
• Animal feed supplement product line launched
• Hemp contains significant amounts of Omega
fatty acids with proven health benefits
• Hempco’s line of packaged foods are sold under
the brand “Planet Hemp” and are distributed
globally in seven countries
• Hemp is a potential source of CBD
Health Canada proposals would allow for whole-
plant utilization model, making hemp low-cost
source of CBD material
Aurora Cannabis Inc. Management Presentation 32LEADERSHIP
33Experienced Leadership Team
Terry Booth Cam Battley Darryl Vleeming
CEO Chief Corporate Officer Chief Information Officer
CEO of 6 successful companies Deep experience in pharma and over 20 years of experience in
25 years experience in highly cannabis sectors Senior IT leadership, project
regulated industries Board member Cannabis delivery, and IT strategic planning
Canada at publicly traded international
corporations, with a specific
focus on driving business value.
Steve Dobler Glen Ibbott
President CFO
Successful entrepreneur, member of Strong senior financial executive
many public companies’ board of with deep life sciences sector
directors. Responsible for raising experience
substantial funds for Aurora
Neil Belot Allan Cleiren
Chief Global Business COO
Development Officer Experienced operational
Former executive director of executive with nearly three
Cannabis Canada - Canada's trade decades leadership experience
association for Licensed Producers at private and public companies
Aurora Cannabis Inc. Management Presentation 34Board of Directors
Michael Singer Adam Szweras Diane Jang
Chairman Partner, Fogler, Rubinoff LLP
Experienced securities
A business consultant,
specializing in strategic
CFO, Clementia
lawyer. Founder of a US planning for sustainable
Pharmaceuticals
developer of marijuana success, growth and
Former CFO, Bedrocan
and hemp oil, and edible profitability, with over 27
Cannabis Corp.
products. years of business
experience in the
Consumer Packaged
Goods industry
Steve Dobler Dr. Jason Dyck
President, Aurora Professor, Department of
Successful entrepreneur, Pediatrics and Director of
member of many public Cardiovascular
companies’ board of Research Centre,
directors. Responsible for University of Alberta
raising substantial funds
for Aurora
Joseph del Moral Terry Booth
President, CanvasRx CEO, Aurora
Experienced executive in CEO of 6 successful
regulated industries companies
Exited last company to Just 25 years experience
Energy (JE.TO) in highly regulated
industries
Aurora Cannabis Inc. Management Presentation 35HIGHLIGHTS
SCALE
• Upon completion, five facilities
• ~ 200,000 kg per annum production capacity1
• Technologically most advanced facilities =>
ultra low cost of production
• Global reach
• Pedanios - Germany & EU Fastest patient sign up
• Cann Group – Australia rate in industry
• Aurora Nordic - Denmark
Scale to service both
INNOVATION
rapidly growing medical
market and seize
• Disruptive extraction technology
legalization opportunity
• First mobile app for ordering medical cannabis
• Customer care: same day delivery in two
metropolitan areas Extremely well capitalized
to pursue global
DIFFERENTIATION expansion opportunity
• High quality products
• BC Northern Lights & Urban Cultivator: addressing home
grow and micro green markets
• Hempco Food & Fiber: new products, new health life-
style markets, low-cost source of CBD materia 1 prorated for 51% interest in Aurora Nordic and 17% interest in TGOD 36
• Namaste partnership delivering product differentiationAGILITY INNOVATION EXECUTION EXPANSION
Talented, experienced management team driving the sector's
fastest growth in customers, revenues and shareholder value
37Aurora Information
Established ~500 Employees Head Office
2013 7 Directors 1500 -1199 West Hastings St.
Vancouver, BC V6E 3T5
TSX: OTCQX:
ACB ACBFF
Aurora Cannabis Inc. Management Presentation 38Capital Summary
January 8, 2018
TSX listed, ticker symbol ACB
Securities Market Cap - Basic
Issued & Outstanding Shares 470,194,953 $6.5 Billion
Options 21,580,724
Warrants 11,037,886
Share Price -
Restricted stock units 2,000,000 January 8, 2018
Convertible debentures shares $13.89
17,692,308
reserved for issuance
Fully Diluted 522,505,871
Strong balance sheet with pro-forma Cash and Marketable Securities Balance
Aurora Cannabis Inc. Management Presentation 39
> $700 millionContact Information
Cam Battley Marc Lakmaaker, Director IR &
Chief Corporate Officer Corporate Development
+1 (905) 878-5525 +1 (647) 269-5523
cam@auroramj.com Marc.lakmaaker@auroramj.com
40You can also read
